Mendel Capital Management LLC Veru Inc. Transaction History

Mendel Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$1.16 - $6.41 $5,301 - $29,293	4,570 Added 8.27%	59,833 $69,000
Q4 2022 Jan 23, 2023	BUY	$4.78 - $15.01 $129,968 - $408,121	27,190 Added 96.85%	55,263 $0
Q3 2022 Oct 25, 2022	BUY	$10.22 - $23.7 $32,346 - $75,010	3,165 Added 12.71%	28,073 $323,000
Q2 2022 Jul 26, 2022	BUY	$4.35 - $15.85 $108,349 - $394,791	24,908 New	24,908 $281,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Mendel Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mendel Capital Management LLC with notifications on news.